| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionation
|
Pöttgen, C.
|
|
2013
|
49 |
9 |
p. 2107-2115
9 p.
|
artikel
|
| 2 |
A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis
|
Georges, Steven
|
|
2013
|
49 |
9 |
p. 2253-2263
11 p.
|
artikel
|
| 3 |
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours
|
Infante, Jeffrey R.
|
|
2013
|
49 |
9 |
p. 2077-2085
9 p.
|
artikel
|
| 4 |
A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification
|
Xia, Wei-Xiong
|
|
2013
|
49 |
9 |
p. 2152-2160
9 p.
|
artikel
|
| 5 |
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer
|
Frigerio, B.
|
|
2013
|
49 |
9 |
p. 2223-2232
10 p.
|
artikel
|
| 6 |
Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials
|
Okines, A.F.C.
|
|
2013
|
49 |
9 |
p. 2116-2125
10 p.
|
artikel
|
| 7 |
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
|
Droeser, Raoul A.
|
|
2013
|
49 |
9 |
p. 2233-2242
10 p.
|
artikel
|
| 8 |
Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort
|
Iacovelli, Roberto
|
|
2013
|
49 |
9 |
p. 2134-2142
9 p.
|
artikel
|
| 9 |
Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas
|
Czabanka, M.
|
|
2013
|
49 |
9 |
p. 2243-2252
10 p.
|
artikel
|
| 10 |
Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities
|
Mesher, David
|
|
2013
|
49 |
9 |
p. 2179-2186
8 p.
|
artikel
|
| 11 |
Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: Identification rate and nodal outcome
|
Donker, Mila
|
|
2013
|
49 |
9 |
p. 2093-2100
8 p.
|
artikel
|
| 12 |
Corrigendum to “Risk adapted chemotherapy for localised Ewing’s sarcoma of bone: The French EW93 study” [Eur. J. Cancer 48 (9) (2012) 1376–1385]
|
Gaspar, Nathalie
|
|
2013
|
49 |
9 |
p. 2276-
1 p.
|
artikel
|
| 13 |
Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary care
|
Tørring, Marie Louise
|
|
2013
|
49 |
9 |
p. 2187-2198
12 p.
|
artikel
|
| 14 |
Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker
|
Morgan, Richard
|
|
2013
|
49 |
9 |
p. 2214-2222
9 p.
|
artikel
|
| 15 |
Functional CYP1A1 genetic variants, alone and in combination with smoking, contribute to development of head and neck cancers
|
Liu, Li
|
|
2013
|
49 |
9 |
p. 2143-2151
9 p.
|
artikel
|
| 16 |
Oral adjuvant clodronate therapy could improve overall survival in early breast cancer: Results from an updated systematic review and meta-analysis
|
Zhu, Jianhong
|
|
2013
|
49 |
9 |
p. 2086-2092
7 p.
|
artikel
|
| 17 |
Proven non-carriers in BRCA families have an earlier age of onset of breast cancer
|
Vos, Janet R.
|
|
2013
|
49 |
9 |
p. 2101-2106
6 p.
|
artikel
|
| 18 |
Recreational and household physical activity at different time points and DNA global methylation
|
White, Alexandra J.
|
|
2013
|
49 |
9 |
p. 2199-2206
8 p.
|
artikel
|
| 19 |
Reply to Araki et al.
|
Lipton, Allan
|
|
2013
|
49 |
9 |
p. 2266-2268
3 p.
|
artikel
|
| 20 |
Response to letter commenting on paper EJC-D-12-01401: Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality
|
McCowan, Colin
|
|
2013
|
49 |
9 |
p. 2273-
1 p.
|
artikel
|
| 21 |
Re: Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of three pivotal, randomised, phase 3 trials
|
Araki, Kazuhiro
|
|
2013
|
49 |
9 |
p. 2264-2265
2 p.
|
artikel
|
| 22 |
Risk of oesophageal adenocarcinoma among individuals born preterm or small for gestational age
|
Lina, Forssell
|
|
2013
|
49 |
9 |
p. 2207-2213
7 p.
|
artikel
|
| 23 |
Structural genome variations in individuals with childhood cancer and tumour predisposition syndromes
|
Hopman, Saskia
|
|
2013
|
49 |
9 |
p. 2170-2178
9 p.
|
artikel
|
| 24 |
The impact of aspirin use on colorectal cancer patients
|
Sahin, Ibrahim Halil
|
|
2013
|
49 |
9 |
p. 2274-2275
2 p.
|
artikel
|
| 25 |
The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: A status report in France in 2011
|
Lièvre, A.
|
|
2013
|
49 |
9 |
p. 2126-2133
8 p.
|
artikel
|
| 26 |
The PARAMOUNT study and the re-challenge chemotherapy issue in advanced non-small cell lung cancer
|
Cufer, Tanja
|
|
2013
|
49 |
9 |
p. 2269-2270
2 p.
|
artikel
|
| 27 |
The PARAMOUNT study and the re-challenge chemotherapy issue in advanced non-small cell lung cancer
|
Gridelli, Cesare
|
|
2013
|
49 |
9 |
p. 2271-2272
2 p.
|
artikel
|
| 28 |
αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I–II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma
|
Ducassou, Anne
|
|
2013
|
49 |
9 |
p. 2161-2169
9 p.
|
artikel
|
Tijdschrift beschrijving